Latest Ai Platforms News

Pathkey.AI reports strong validation of its TrialKey AI platform’s predictive accuracy and announces key leadership changes as it advances toward commercial scale.

Aspermont Limited reports its 37th consecutive quarter of subscription growth, launching its Mining-IQ AI platform and securing a landmark $550k contract with Rio Tinto.

Decidr AI Industries moves to acquire full ownership of Decidr.ai, launches its unified AI platform DecidrOS, and reports robust Q1 FY26 progress with significant capital raising and expanding partnerships.

Straker Limited has extended its partnership with IBM for three more years, locking in a NZ$28 million contract and expanding collaboration into AI-driven language model development.

Hiremii Limited reported a 6% revenue increase and an 18% rise in gross profit for Q1 FY26, driven by global job board integration and a successful capital raise to fuel its AI-powered recruitment platform.

Spectur Limited reported a strategic revenue shift in Q1 FY26, with SaaS recurring revenue growing 5% year-on-year despite an overall 9% quarterly revenue dip. The company also raised $2.3 million to accelerate its solar-powered AI platform development.

FlexiRoam Limited has reported its strongest quarterly operating cash flow ever, signalling a successful business reset and setting the stage for growth with a new AI-assisted connectivity platform.

dorsaVi reports breakthrough RRAM sensor performance and secures a major US physical therapy deal, backed by a $5 million capital raise and new leadership appointments.

Algorae Pharmaceuticals has broadened its commercial footprint in Australia and New Zealand through key licensing agreements, while advancing its AI-driven drug discovery platform and strengthening leadership.

Janison Education Group reported solid FY25 results with 9% revenue growth and the commercial launch of its AI platform Jai, positioning itself strongly in the expanding global digital assessment market.

Algorae Pharmaceuticals has signed a binding term sheet with India’s Cadila Pharmaceuticals to introduce two generic medicines targeting cardiovascular and metabolic disorders in Australia and New Zealand.

Vection Technologies has secured $1.5 million in AI-driven enterprise orders spanning agritech, cybersecurity, real estate, healthcare, and public administration, reinforcing its recurring revenue model and cross-sector appeal.